New actions of an old friend: perivascular adipose tissue's adrenergic mechanisms

British Journal of Pharmacology

Volumn 174, Issue 20, 2017, Pages 3454-3465

  Ayala Lopez, Nadia ^a   Watts, Stephanie W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; AMINE OXIDASE (COPPER CONTAINING); ANGIOTENSIN II; CATECHOLAMINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN KINASE C; RESISTIN; SIBUTRAMINE; VENLAFAXINE; ADRENERGIC RECEPTOR;

ADRENERGIC ACTIVITY; ADRENERGIC SYSTEM; AUTONOMIC INNERVATION; BLOOD PRESSURE REGULATION; CATECHOLAMINE METABOLISM; CATECHOLAMINE SYNTHESIS; DEPRESSION; FEEDBACK SYSTEM; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MACROPHAGE; NONHUMAN; OBESITY; PERIVASCULAR ADIPOSE TISSUE; PRIORITY JOURNAL; REVIEW; WHITE ADIPOSE TISSUE; ADIPOSE TISSUE; ANIMAL; BLOOD VESSEL; INNERVATION; METABOLISM; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; BLOOD VESSELS; CATECHOLAMINES; HUMANS; RECEPTORS, ADRENERGIC; SYMPATHETIC NERVOUS SYSTEM;

EID: 85006354978     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13663     Document Type: Review

References (116)

1. Abella A, Garcia-Vicente S, Viguerie N, Ros-Baro A, Camps M, Palacin M et al. (2004). Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Diabetologia 47: 429–438.
2. Abrass CK, O'Connor SW, Scarpace PJ, Abrass IB (1985). Characterization of the beta-adrenergic receptor of the rat peritoneal macrophage. J Immunol 135: 1338–1341.
3. Aghamohammadzadeh R, Heagerty AM (2012). Obesity-related hypertension: epidemiology, pathophysiology, treatments, and the contribution of perivascular adipose tissue. Ann Med 44 (Suppl. 1): S74–S84.
4. Alexander SPH, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015a). The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol 172: 5744–5869.
5. Alexander SPH, Catterall WA, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015b). The Concise Guide to PHARMACOLOGY 2015/16: Voltage-gated ion channels. Br J Pharmacol 172: 5904–5941.
6. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015c). The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors. Br J Pharmacol 172: 5979–6023.
7. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015d). The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol 172: 6024–6109.
8. Alexander SPH, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E et al. (2015e). The Concise Guide to PHARMACOLOGY 2015/16: Transporters. Br J Pharmacol 172: 6110–6202.
9. Ayala-Lopez N, Jackson WF, Burnett R, Wilson JN, Thompson JM, Watts SW (2015). Organic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue. Am J Physiol Heart Circ Physiol 309: H1904–H1914.
10. Ayala-Lopez N, Martini M, Jackson WF, Darios E, Burnett R, Seitz B et al. (2014). Perivascular adipose tissue contains functional catecholamines. Pharmacol Res Perspect 2: e00041.
11. Ballard K, Malmfors T, Rosell S (1974). Adrenergic innervation and vascular patterns in canine adipose tissue. Microvasc Res 8: 164–171.
12. Bao J-Y, Huang Y, Wang F, Peng Y-P, Qiu Y-H (2007). Expression of alpha-AR subtypes in T lymphocytes and role of the alpha-ARs in mediating modulation of T cell function. Neuroimmunomodulation 14: 344–353.
13. Bartness TJ, Song CK (2007). Sympathetic and sensory innervation of white adipose tissue. J of Lipid Res 48: 1655–1672.
14. Bhattacharjee A, Shukla M, Yakubenko VP, Mulya A, Kundu S, Cathcart MK (2013). IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radic Biol Med 54: 1–16.
15. Brown NK, Zhou Z, Zhang J, Zeng R, Wu J, Eitzman DT et al. (2014). Perivascular adipose tissue in vascular function and disease: a review of current research and animal models. Arterioscler Thromb Vasc Biol 34: 1621–1630.
16. Brown SW, Meyers RT, Brennan KM, Rumble JM, Narasimhachari N, Perozzi EF et al. (2003). Catecholamines in a macrophage cell line. J Neuroimmunol 135: 47–55.
17. Brunetti L, Orlando G, Recinella L, Michelotto B, Ferrante C, Vacca M (2004). Resistin, but not adiponectin, inhibits dopamine and norepinephrine release in the hypothalamus. Eur J Pharmacol 493: 41–44.
18. Bulloch JM, Daly CJ (2014). Autonomic nerves and perivascular fat: interactive mechanisms. Pharmacol Ther 143: 61–73.
19. Bussey CE, Withers SB, Aldous RG, Edwards G, Heagerty AM (2016). Obesity-related perivascular adipose tissue damage is reversed by sustained weight loss in the rat. Arterioscler Thromb Vasc Biol 36: 1377–1385.
20. Cassis LA (1993). Role of angiotensin II in brown adipose thermogenesis during cold acclimation. Am J Physiol 265: E860–E865.
21. Chaitidis P, Billett E, Kuban RJ, Ungethuem U, Kuhn H (2005). Expression regulation of MAO isoforms in monocytic cells in response to Th2 cytokines. Med Sci Monit 11: BR259–BR265.
22. Chaldakov GN, Beltowsky J, Ghenev PI, Fiore M, Panayotov P, Rančič G et al. (2012). Adipoparacrinology – vascular periadventitial adipose tissue (tunica adiposa) as an example. Cell Biol Int 36: 327–330.
23. Chaldakov GN, Fiore M, Ghenev PI, Beltowski J, Rancic G, Tuncel N et al. (2014). Triactome: neuro-immune-adipose interactions. Implication in vascular biology. Front Immunol 5: 130.
24. Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G et al. (2009). Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res 104: 541–549.
25. Chi DS, Fitzgerald SM, Pitts S, Cantor K, King E, Lee SA et al. (2004). MAPK-dependent regulation of IL-1- and beta-adrenoreceptor-induced inflammatory cytokine production from mast cells: implications for the stress response. BMC Immunol 5: 22.
26. Chi DS, Qui M, Krishnaswamy G, Li C, Stone W (2003). Regulation of nitric oxide production from macrophages by lipopolysaccharide and catecholamines. Nitric Oxide 8: 127–132.
27. Cinti S (2009). Transdifferentiation properties of adipocytes in the adipose organ. AJP Endocrinol Metab 297: E977–E986.
28. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS (1996). Role of leptin in fat regulation. Nature 380: 677.
29. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al. (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334: 292–295.
30. Contreras GA, Lee Y, Mottillo EP, Granneman JG (2014). Inducible brown adipocytes in subcutaneous inguinal white fat: the role of continuous sympathetic stimulation. AJP Endocrinol Metab 307: E793–E799.
31. Costa RM, Filgueira FP, Tostes RC, Carvalho MHC, Akamine EH, Lobato NS (2016). H2O2 generated from mitochondrial electron transport chain in thoracic perivascular adipose tissue is crucial for modulation of vascular smooth muscle contraction.
32. Couillard C, Mauriège P, Prud'homme D, Nadeau A, Tremblay A, Bouchard C et al. (1997). Plasma leptin concentrations: gender differences and associations with metabolic risk factors for cardiovascular disease. Diabetologia 40: 1178–1184.
33. Cox SL, Trendelenburg AU, Starke K (1999). Prejunctional angiotensin receptors involved in the facilitation of noradrenaline release in mouse tissues. Br J Pharmacol 127: 1256–1262.
34. Diculescu I, Stoica M (1970). Fluorescence histochemical investigation on the adrenergic innervation of the white adipose tissue in the rat. J Neurovisc Relat 32: 25–36.
35. Elliott J, Callingham BA, Sharman DF (1989a). Metabolism of amines in the isolated perfused mesenteric arterial bed of the rat. Br J Pharmacol 98: 507–514.
36. Elliott J, Callingham BA, Sharman DF (1989b). The influence of amine metabolizing enzymes on the pharmacology of tyramine in the isolated perfused mesenteric arterial bed of the rat. Br J Pharmacol 98: 515–522.
37. Evans BA, Agar L, Summers RJ (1999). The role of the sympathetic nervous system in the regulation of leptin synthesis in C57BL/6 mice. FEBS Lett 444: 149–154.
38. Fang C, Lei J, Zhou S, Zhang Y, Yuan G, Wang J (2013). Association of higher resistin levels with inflammatory activation and endothelial dysfunction in patients with essential hypertension. Chin Med J (Engl) 126: 646–649.
39. Fernandez-Alfonso MS, Gil-Ortega M, Garcia-Prieto CF, Aranguez I, Ruiz-Gayo M, Somoza B (2013). Mechanisms of perivascular adipose tissue dysfunction in obesity. Int J Endocrinol 2013: 402053.
40. Filip A, Pinzano A, Bianchi A, Fève B, Jalkanen S, Gillet P et al. (2016). Expression of the semicarbazide-sensitive amine oxidase in articular cartilage: its role in terminal differentiation of chondrocytes in rat and human. Osteoarthritis Cartilage 24: 1223–1234.
41. Fitzgibbons TP, Kogan S, Aouadi M, Hendricks GM, Straubhaar J, Czech MP (2011). Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation. Am J Physiol Heart Circ Physiol 301: H1425–H1437.
42. Fliers E, Kreier F, Voshol PJ, Havekes LM, Sauerwein HP, Kalsbeek A et al. (2003). White adipose tissue: getting nervous. J Neuroendocrinol 15: 1005–1010.
43. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY et al. (2007). Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116: 39–48.
44. Galvez-Prieto B, Somoza B, Gil-Ortega M, Garcia-Prieto CF, de Las Heras AI, Gonzalez MC et al. (2012). Anticontractile effect of perivascular adipose tissue and leptin are reduced in hypertension. Front Pharmacol 3: 103.
45. Galvez B, de Castro J, Herold D, Dubrovska G, Arribas S, Gonzalez MC et al. (2006). Perivascular adipose tissue and mesenteric vascular function in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 26: 1297–1302.
46. Gao YJ (2007). Dual modulation of vascular function by perivascular adipose tissue and its potential correlation with adiposity/lipoatrophy-related vascular dysfunction. Curr Pharm Des 13: 2185–2192.
47. Gao YJ, Takemori K, Su LY, An WS, Lu C, Sharma AM et al. (2006). Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. Cardiovasc Res 71: 363–373.
48. Gettys TW, Harkness PJ, Watson PM (1996). The beta 3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology 137: 4054–4057.
49. Gil-Ortega M, Somoza B, Huang Y, Gollasch M, Fernandez-Alfonso MS (2015). Regional differences in perivascular adipose tissue impacting vascular homeostasis. Trends Endocrinol Metab 26: 367–375.
50. Giordano A, Song CK, Bowers RR, Ehlen JC, Frontini A, Cinti S et al. (2006). White adipose tissue lacks significant vagal innervation and immunohistochemical evidence of parasympathetic innervation. Am J Physiol Regul Integr Comp Physiol 291: R1243–R1255.
51. Goossens GH, Jocken JWE, Blaak EE, Schiffers PM, Saris WHM, van Baak MA (2007). Endocrine role of the renin-angiotensin system in human adipose tissue and muscle: effect of beta-adrenergic stimulation. Hypertension 49: 542–547.
52. Granneman JG, Li P, Lu Y, Tilak J (2004). Seeing the trees in the forest: selective electroporation of adipocytes within adipose tissue. Am J Physiol Endocrinol Metab 287: E574–E582.
53. Guzik TJ, Marvar PJ, Czesnikiewicz-Guzik M, Korbut R (2007). Perivascular adipose tissue as a messenger of the brain-vessel axis: Role in vascular inflammation and dysfunction. J Physiol Pharmacol 58: 591–610.
54. El Hadri K, Moldes M, Mercier N, Andreani M, Pairault J, Feve B (2002). Semicarbazide-sensitive amine oxidase in vascular smooth muscle cells: differentiation-dependent expression and role in glucose uptake. Arterioscler Thromb Vasc Biol 22: 89–94.
55. Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S et al. (2010). Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem 285: 17271–17276.
56. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI (1997). Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 100: 270–278.
57. Inoue K, Nishino T, Creveling CR (1991). Immunocytochemical evidence for the site of O-methylation in rat dental pulp. J Dent Res 70: 966–969.
58. Jacobsson JA, Haitina T, Lindblom J, Fredriksson R (2007). Identification of six putative human transporters with structural similarity to the drug transporter SLC22 family. Genomics 90: 595–609.
59. Josefsson E, Bergquist J, Ekman R, Tarkowski A (1996). Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology 88: 140–146.
60. Kalil GZ, Haynes WG (2012). Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications. Hypertens Res 35: 4–16.
61. Ketonen J, Shi J, Martonen E, Mervaala E (2010). Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57Bl/6 mice. Circ J 74: 1479–1487.
62. Kienecker EW, Knoche H (1978). Sympathetic innervation of the pulmonary artery, ascending aorta, and coronar glomera of the rabbit. A fluorescence microscopic study. Cell Tissue Res 188: 329–333.
63. King VL, Dwoskin LP, Cassis LA (1999). Cold exposure regulates the norepinephrine uptake transporter in rat brown adipose tissue. Am J Physiol 276: R143–R151.
64. King VL, English VL, Bharadwaj K, Cassis LA (2013). Angiotensin II stimulates sympathetic neurotransmission to adipose tissue. Physiol Rep 1: 1–12.
65. Kotchen TA (2010). Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens 23: 1170–1178.
66. Kvetnansky R, Ukropec J, Laukova M, Manz B, Pacak K, Vargovic P (2012). Stress stimulates production of catecholamines in rat adipocytes. Cell Mol Neurobiol 32: 801–813.
67. Lafontan M, Berlan M (1993). Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 34: 1057–1091.
68. Lafontan M, Bousquet-Melou A, Galitzky J, Barbe P, Carpéné C, Langin D et al. (1995). Adrenergic receptors and fat cells: differential recruitment by physiological amines and homologous regulation. Obes Res 3 (Suppl. 4): 507S–514S.
69. Laukova M, Vargovic P, Vlcek M, Lejavova K, Hudecova S, Krizanova O et al. (2013). Catecholamine production is differently regulated in splenic T- and B-cells following stress exposure. Immunobiology 218: 780–789.
70. Licht CMM, de Geus EJC, Seldenrijk A, van Hout HPJ, Zitman FG, van Dyck R et al. (2009). Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension (Dallas, Tex. 1979)53: 631–638.
71. Löhn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM (2002). Periadventitial fat releases a vascular relaxing factor. FASEB J 16: 1057–1063.
72. Lu C, Su LY, Lee RM, Gao YJ (2010). Mechanisms for perivascular adipose tissue-mediated potentiation of vascular contraction to perivascular neuronal stimulation: the role of adipocyte-derived angiotensin II. Eur J Pharmacol 634: 107–112.
73. Luque CA, Rey JA (1999). Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity. Ann Pharmacother 33: 968–978.
74. Lynch FM, Withers SB, Yao Z, Werner ME, Edwards G, Weston AH et al. (2013). Perivascular adipose tissue-derived adiponectin activates BK(Ca) channels to induce anticontractile responses. Am J Physiol Heart Circ Physiol 304: H786–H795.
75. Manka D, Chatterjee TK, Stoll LL, Basford JE, Konaniah ES, Srinivasan R et al. (2014). Transplanted perivascular adipose tissue accelerates injury-induced neointimal hyperplasia: role of monocyte chemoattractant protein-1. Arterioscler Thromb Vasc Biol 34: 1723–1730.
76. Marques C, Meireles M, Norberto S, Leite J, Freitas J, Pestana D et al. (2015). High-fat diet-induced obesity Rat model: a comparison between Wistar and Sprague–Dawley Rat. Adipocyte 5: 11–21.
77. Matthias A, Ohlson KBE, Fredriksson JM, Jacobsson A, Nedergaard J, Cannon B (2000). Thermogenic responses in brown fat cells are fully UCP1-dependent. UCP2 or UCP3 do not substitute for UCP1 in adrenergically or fatty acid-induced thermogenesis. J Biol Chem 275: 25073–25081.
78. Mercier N, Moldes M, Hadri KE, Fève B (2001). Semicarbazide-sensitive amine oxidase activation promotes adipose conversion of 3 T3-L1 cells. Biochem J 358: 335–342.
79. Murano I, Barbatelli G, Giordano A, Cinti S (2009). Noradrenergic parenchymal nerve fiber branching after cold acclimatisation correlates with brown adipocyte density in mouse adipose organ. J Anat 214: 171–178.
80. Nguyen KD, Qiu Y, Cui X, Goh YPS, Mwangi J, David T et al. (2011). Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 480: 104–108.
81. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M et al. (2009). CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15: 914–920.
82. Pizzinat N, Marti L, Remaury A, Leger F, Langin D, Lafontan M et al. (1999). High expression of monoamine oxidases in human white adipose tissue: evidence for their involvement in noradrenaline clearance. Biochem Pharmacol 58: 1735–1742.
83. Qiu YH, Peng YP, Jiang JM, Wang JJ (2004). Expression of tyrosine hydroxylase in lymphocytes and effect of endogenous catecholamines on lymphocyte function. Neuroimmunomodulation 11: 75–83.
84. Rayner DV, Simón E, Duncan JS, Trayhurn P (1998). Hyperleptinaemia in mice induced by administration of the tyrosine hydroxylase inhibitor α-methyl-p-tyrosine. FEBS Lett 429: 395–398.
85. Rayner DV, Trayhurn P (2001). Regulation of leptin production: Sympathetic nervous system interactions. J Mol Med 79: 8–20.
86. Rittig K, Dolderer JH, Balletshofer B, Machann J, Schick F, Meile T et al. (2012). The secretion pattern of perivascular fat cells is different from that of subcutaneous and visceral fat cells. Diabetologia 55: 1514–1525.
87. Rubanyi GM (1988). Vascular effects of oxygen-derived free radicals. Free Radic Biol Med 4: 107–120.
88. Shek EW, Brands MW, Hall JE (1998). Chronic leptin infusion increases arterial pressure. Hypertension 31: 409–414.
89. Shi H, Bartness TJ (2001). Neurochemical phenotype of sympathetic nervous system outflow from brain to white fat. Brain Res Bull 54: 375–385.
90. Sir A, D'Souza RF, Uguz S, George T, Vahip S, Hopwood M et al. (2005). Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms. J Clin Psychiatry 66: 1312–1320.
91. Slavin BG, Ballard KW (1978). Morphological studies on the adrenergic innervation of white adipose tissue. Anat Rec 191: 377–389.
92. Smith MM, Minson CT (2012). Obesity and adipokines: effects on sympathetic overactivity. J Physiol 590: 1787–1801.
93. Soltis EE, Cassis LA (1991). Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin Exp Hypertens A 13: 277–296.
94. Souki A, Arraíz N, Prieto C, Pérez Jiménez F, Valero P, Amell A et al. (2016). Association between resistin serum levels and dimension and body composition variables in children and adolescents. Rev Médica Chile 144: 307–316.
95. Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SP et al. (2016). The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucl. Acids Res. 44: D1054–D1068.
96. Spengler RN, Allen RM, Remick DG, Strieter RM, Kunkel SL (1990). Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J Immunol 145: 1430–1434.
97. Spradley FT, Ho DH, Pollock JS (2016). Dahl SS rats demonstrate enhanced aortic perivascular adipose tissue-mediated buffering of vasoconstriction through activation of NOS in the endothelium. Am J Physiol Regul Integr Comp Physiol 310: R286–R296.
98. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM et al. (2001). The hormone resistin links obesity to diabetes. Nature 409: 307–312.
99. Stunes AK, Reseland JE, Hauso O, Kidd M, Tommeras K, Waldum HL et al. (2011). Adipocytes express a functional system for serotonin synthesis, reuptake and receptor activation. Diabetes Obes Metab 13: 551–558.
100. Sturza A, Leisegang MS, Babelova A, Schroder K, Benkhoff S, Loot AE et al. (2013). Monoamine oxidases are mediators of endothelial dysfunction in the mouse aorta. Hypertension 62: 140–146.
101. Szasz T, Webb RC (2012). Perivascular adipose tissue: more than just structural support. Clin Sci 122: 1–12.
102. Tang-Christensen M, Havel PJ, Jacobs RR, Larsen PJ, Cameron JL (1999). Central administration of leptin inhibits food intake and activates the sympathetic nervous system in Rhesus Macaques 1. J Clin Endocrinol Metab 84: 711–717.
103. Thang LV, Demel SL, Crawford R, Kaminski NE, Swain GM, Van Rooijen N et al. (2015). Macrophage depletion lowers blood pressure and restores sympathetic nerve α2-adrenergic receptor function in mesenteric arteries of DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol 309: H1186–H1197.
104. Thase ME (1998). Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry 59: 502–508.
105. Vargovic P, Ukropec J, Laukova M, Cleary S, Manz B, Pacak K et al. (2011). Adipocytes as a new source of catecholamine production. FEBS Lett 585: 2279–2284.
106. Vargovic P, Ukropec J, Laukova M, Kurdiova T, Balaz M, Manz B et al. (2013). Repeated immobilization stress induces catecholamine production in rat mesenteric adipocytes. Stress 16: 340–352.
107. Vasdev S, Gill V, Singal P (2007). Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications. Cell Biochem Biophys 49: 48–63.
108. Vega A, Chacón P, Monteseirín J, Bekay RE, Álvarez M, Alba G et al. (2004). A new role for monoamine oxidases in the modulation of macrophage-inducible nitric oxide synthase gene expression. J Leukoc Biol 75: 1093–1101.
109. Vida G, Pena G, Kanashiro A, del Rocio Thompson-Bonilla M, Palange D, Deitch EA et al. (2011). Beta2-Adrenoreceptors of regulatory lymphocytes are essential for vagal neuromodulation of the innate immune system. FASEB J 25: 4476–4485.
110. Visentin V, Boucher J, Bour S, Prevot D, Castan I, Carpene C et al. (2005). Influence of high-fat diet on amine oxidase activity in white adipose tissue of mice prone or resistant to diet-induced obesity. J Physiol Biochem 61: 343–352.
111. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW (2003). Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796–1808.
112. Weston AH, Egner I, Dong Y, Porter EL, Heagerty AM, Edwards G (2013). Stimulated release of a hyperpolarizing factor (ADHF) from mesenteric artery perivascular adipose tissue: involvement of myocyte BKCa channels and adiponectin. Br J Pharmacol 169: 1500–1509.
113. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE et al. (2001). Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930–1935.
114. Wofford M (2001). Antihypertensive effect of α- and β-adrenergic blockade in obese and lean hypertensive subjects. Am J Hypertens 14: 694–698.
115. World Health Organization (2014). Obesity and overweight (Fact Sheet 311).
116. Zeng W, Pirzgalska RM, Pereira MMA, Kubasova N, Barateiro A, Seixas E et al. (2015). Sympathetic neuro-adipose connections mediate leptin-driven lipolysis. Cell 163: 84–94.